Back to search

Article

Mutation-specific impairment of TET2 and DNMT3A enzymatic activity predicts clonal hematopoiesis disease risk

2026-04-05

Abstract excerpt

Clonal hematopoiesis of indeterminate potential (CHIP) driven by somatic mutations in TET2 and DNMT3A is present in >10% of adults over 60 and confers substantial risk for hematologic malignancy and cardiovascular disease, yet the majority of patients with CHIP do not progress to disease. Analyzing 1,020,538 individuals across three biobanks (UK Biobank, All of Us, BioVU), we show that a discrete subset of enzymat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
61610151-0ac1-5444-90e2-dd4231019377
DOI
10.64898/2026.04.03.26350108
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Mutation-specific impairment of TET2 and DNMT3A enzymatic activity predicts clonal hematopoiesis disease riskDOI 10.64898/2026.04.03.26350108
Select a neighboring publication to make it the new centre.